Delayed Resolution of Acute Inflammation in Ulcerative Colitis Is Associated with Elevated Cytokine Release Downstream of TLR4

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Rahman, Farooq Z ^a   Smith, Andrew M ^a   Hayee, Bu'Hussain ^a   Marks, Daniel J B ^a   Bloom, Stuart L ^b   Segal, Anthony W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYTOKINE; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

ARTICLE; BIOSYNTHESIS; DNA MICROARRAY; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; LEUKOCYTE; MACROPHAGE; METABOLISM; MONOCYTE; PATHOLOGY; TREATMENT OUTCOME; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CYTOKINES; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERFERON-BETA; LEUKOCYTES; MACROPHAGES; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 79952115519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009891     Document Type: Article

References (37)

1. Brain O, Travis SP (2008) Therapy of ulcerative colitis: state of the art. Curr Opin Gastroenterol 24: 469-474.
2. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
3. Farrell RJ, Peppercorn MA (2002) Ulcerative colitis. Lancet 359: 331-340.
4. Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, et al. (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40: 710-712.
5. Franke A, Balschun T, Karlsen TH, Hedderich J, May S, et al. (2008) Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40: 713-715.
6. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41: 216-220.
7. O'Neill LA (2008) The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 226: 10-8.:10-18.
8. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, et al. (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6: 565-570.
9. Marks DJ, Rahman FZ, Novelli M, Yu RC, McCartney S, et al. (2006) An exuberant inflammatory response to E coli: implications for the pathogenesis of ulcerative colitis and pyoderma gangrenosum. Gut 55: 1662-1663.
10. O'Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364.
11. Hoebe K, Janssen EM, Kim SO, Alexopoulou L, Flavell RA, et al. (2003) Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 4: 1223-1229.
12. Cekic C, Casella CR, Eaves CA, Matsuzawa A, Ichijo H, et al. (2009) Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J Biol Chem.
13. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, et al. (2006) Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439: 204-207.
14. Weighardt H, Jusek G, Mages J, Lang R, Hoebe K, et al. (2004) Identification of a TLR4-and TRIF-dependent activation program of dendritic cells. Eur J Immunol 34: 558-564.
15. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, et al. (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175: 3339-3346.
16. Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8: 458-466.
17. Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, et al. (2006) Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 367: 668-678.
18. Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, et al. (2009) Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 206: 1883-1897.
19. Ansari N, Abdulla J, Zayyani N, Brahmi U, Taha S, et al. (2006) Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? J Clin Pathol 59: 1066-1072.
20. Heller F, Florian P, Bojarski C, Richter J, Christ M, et al. (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564.
21. Mudter J, Neurath MF (2007) Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 13: 1016-1023.
22. Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, et al. (1999) Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 155: 331-336.
23. Sasaki S, Yoneyama H, Suzuki K, Suriki H, Aiba T, et al. (2002) Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol 32: 3197-3205.
24. Singh UP, Venkataraman C, Singh R, Lillard JW, Jr. (2007) CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets 7: 111-123.
25. Singh UP, Singh S, Singh R, Cong Y, Taub DD, et al. (2008) CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res 28: 31-43.
26. Noguchi A, Watanabe K, Narumi S, Yamagami H, Fujiwara Y, et al. (2007) The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity. J Gastroenterol 42: 947-956.
27. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, et al. (1996) T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184: 241-251.
28. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, et al. (2003) LPSTLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198: 1043-1055.
29. Mavrogiannis C, Papanikolaou IS, Elefsiniotis IS, Psilopoulos DI, Karameris A, et al. (2001) Ulcerative colitis associated with interferon treatment for chronic hepatitis C. J Hepatol 34: 964-965.
30. Schott E, Paul F, Wuerfel JT, Zipp F, Rudolph B, et al. (2007) Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a. World J Gastroenterol 13: 3638-3640.
31. Tursi A (2007) Rapid onset of ulcerative colitis after treatment with PEGinterferon plus ribavirin for chronic hepatitis C. Inflamm Bowel Dis 13: 1189-1190.
32. Pena-Rossi C, Schreiber S, Golubovic G, Mertz-Nielsen A, Panes J, et al. (2008) Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dosefinding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis. Aliment Pharmacol Ther 28: 758-767.
33. Seow CH, Benchimol EI, Griffiths AM, Steinhart AH (2008) Type I interferons for induction of remission in ulcerative colitis. Cochrane Database Syst Rev CD006790.
34. Scarpa M, Behboo R, Angriman I, Termini B, Barollo M, et al. (2004) The role of costimulatory molecules CD80 and CD86 and IFNgamma in the pathogenesis of ulcerative colitis. Dig Dis Sci 49: 1738-1744.
35. Eri R, Kodumudi KN, Summerlin DJ, Srinivasan M (2008) Suppression of colon inflammation by CD80 blockade: Evaluation in two murine models of inflammatory bowel disease. Inflamm Bowel Dis 14: 458-470.
36. Hardarson HS, Baker JS, Yang Z, Purevjav E, Huang CH, et al. (2007) Toll-like receptor 3 is an essential component of the innate stress response in virusinduced cardiac injury. Am J Physiol Heart Circ Physiol 292: H251-H258.
37. Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, et al. (2008) Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1. Eur J Immunol 38: 1194-1203.